Factors Associated with Lung Function Decline in Patients with Non-Tuberculous Mycobacterial Pulmonary Disease

被引:26
|
作者
Lee, Meng-Rui [1 ,2 ]
Yang, Ching-Yao [1 ]
Chang, Kai-Ping [1 ]
Keng, Li-Ta [1 ,3 ]
Yen, David Hung-Tsang [3 ,4 ]
Wang, Jann-Yuan [1 ]
Wu, Huey-Dong [1 ]
Lee, Li-Na [5 ]
Yu, Chong-Jen [1 ]
机构
[1] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan
[2] Taoyuan Gen Hosp, Dept Internal Med, Tao Yuan, Taiwan
[3] Kinmen Hosp, Dept Internal Med, Kinmen, Taiwan
[4] Natl Yang Ming Univ, Taipei Vet Gen Hosp, Dept Emergency Med, Taipei 112, Taiwan
[5] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan
来源
PLOS ONE | 2013年 / 8卷 / 03期
关键词
FORCED EXPIRATORY VOLUME; QUALITY-OF-LIFE; PERFORMANCE ASSESSMENT; TUBERCULOSIS; BRONCHIECTASIS; INFECTIONS; SPIROMETRY; ADULTS; ABSCESSUS; SMOKING;
D O I
10.1371/journal.pone.0058214
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: There is paucity of risk factors on lung function decline among patients with non-tuberculous mycobacteria (NTM) pulmonary disease in literature. Methods: Patients with NTM pulmonary disease between January 2000 and April 2011 were retrospectively selected. Sixty-eight patients had at least two pulmonary function tests within a mean follow-up period of 47 months. Results: Sixty-eight patients were included. They had a median age of 65 years and 65% had impaired lung function (Forced expiratory volume in 1 second [FEV1] <80% of predicted value). The mean FEV1 decline was 48 ml/year. By linear regression, younger age (beta: 0.472, p < 0.001), initial FEV1 >50% of predicted value (beta: 0.349, p = 0.002), male sex (beta: 0.295, p = 0.018), bronchiectasis pattern (beta: 0.232, p = 0.035), and radiographic score >3 (beta: 0.217, p = 0.049) were associated with greater FEV1 decline. Initial FEV1 >50% of predicted value (beta: 0.263, p = 0.032) was also associated with greater FVC annual decline, whereas M. kansasii pulmonary disease was marginally associated with greater annual FVC decline (beta: 0.227, p = 0.062). Conclusions: NTM pulmonary disease is associated with greater decline in lung function in patients who are young, male, with bronchiectasis, and with a high radiographic score. Special attention should be given to patients with these risk factors.
引用
收藏
页数:6
相关论文
共 50 条
  • [11] NON-TUBERCULOUS MYCOBACTERIAL PULMONARY-DISEASE
    SPITZ, HB
    WIOT, JF
    SEMINARS IN ROENTGENOLOGY, 1979, 14 (03) : 244 - 248
  • [12] Impact Of Pulmonary Non-Tuberculous Mycobacterial Treatment On Pulmonary Function Tests In Patients With And Without Established Obstructive Lung Disease
    Mehta, M.
    Chapman, K. R.
    Heffer, M.
    Marras, T. K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [13] Distinguishing between pulmonary tuberculosis and non-tuberculous mycobacterial lung disease
    Kwon, Yong-Soo
    Koh, Won-Jung
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2014, 18 (06) : 633 - 633
  • [14] NON-TUBERCULOUS MYCOBACTERIAL LUNG-DISEASE
    PIERON, R
    VERGEZ, P
    KABBAJ, T
    ZURBACH, J
    GRIVAUX, M
    MALBEC, JC
    SEMAINE DES HOPITAUX, 1985, 61 (41): : 2831 - 2838
  • [15] Non-tuberculous Mycobacterial Lung Disease Presenting as a Solitary Pulmonary Nodule
    Kim, Song Yee
    Lee, Kyung Jong
    Lee, Sang Hoon
    Lee, Sang Kook
    Park, Byung Hoon
    Jung, Ji Ye
    Son, Ji Young
    Yoon, Yoe Wun
    Shim, Hyo Sup
    Kang, Young Ae
    Park, Moo Suk
    Kim, Young Sam
    Chang, Joon
    Kim, Se Kyu
    Moon, Jin Wook
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2010, 69 (01) : 43 - 47
  • [16] Treatment of Non-Tuberculous Mycobacterial Lung Disease
    Julie V. Philley
    Mary Ann DeGroote
    Jennifer R. Honda
    Michael M. Chan
    Shannon Kasperbauer
    Nicholas D. Walter
    Edward D. Chan
    Current Treatment Options in Infectious Diseases, 2016, 8 (4) : 275 - 296
  • [17] Prevalence and risk factors of non-tuberculous mycobacterial pulmonary isolates and infection in interstitial lung disease associated with systemic autoimmune disease
    Shu, C. -c.
    Chen, P. -s.
    Lin, Z. -h.
    Hsiao, C. -t.
    Kuo, C. -c.
    Chiang, H. -y.
    Wu, P. -c.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2024, 42 (05) : 1006 - 1014
  • [18] Prognosis of chronic pulmonary aspergillosis in patients with pulmonary non-tuberculous mycobacterial disease
    Naito, Maiko
    Kurahara, Yu
    Yoshida, Shiomi
    Ikegami, Naoya
    Kobayashi, Takehiko
    Minomo, Shojiro
    Tachibana, Kazunobu
    Tsuyuguchi, Kazunari
    Hayashi, Seiji
    Suzuki, Katsuhiro
    RESPIRATORY INVESTIGATION, 2018, 56 (04) : 326 - 331
  • [19] The roles of neutrophils in non-tuberculous mycobacterial pulmonary disease
    Alkarni, Meyad
    Lipman, Marc
    Lowe, David M.
    ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS, 2023, 22 (01)
  • [20] Non-tuberculous mycobacterial pulmonary disease: a clinical update
    Rokadiya, S.
    Millar, F. R.
    Tiberi, S.
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2018, 79 (08) : C118 - C122